Action HAE HAEMONETICS CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Haemonetics Corporation

Actions

HAE

US4050241003

Marché Fermé - Nyse
Autres places de cotation
 22:00:02 12/06/2024 		Varia. 5j. Varia. 1 janv.
85,93 USD +3,02 % Graphique intraday de Haemonetics Corporation -2,27 % +0,49 %
12/06 Les actions d'Haemonetics augmentent après un relèvement de Needham MT
12/06 HAEMONETICS CORPORATION : Needham & Co. favorable au dossier ZM

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
PR
Haemonetics Announces Proposed Convertible Senior Notes Offering
PR
Haemonetics: Fiscal Q4 Earnings Snapshot
AQ
Haemonetics : 4th Quarter FY24 Earnings Release
PU
Haemonetics : Q4 2024 Analysis Tables & Supplemental Information
PU
Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
AQ
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
PR
Haemonetics Corporation Completes Acquisition of Attune Medical
PR
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
PR
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
PR
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
PR
Haemonetics: Fiscal Q3 Earnings Snapshot
AQ
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
PR
Haemonetics Corporation Completes Acquisition of OpSens Inc.
PR
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS
AQ
Haemonetics: Fiscal Q2 Earnings Snapshot
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HAE
  4. Actualités Haemonetics Corporation
  5. Communiqués